Global pharmaceutical giant Sandoz is undergoing a profound strategic evolution, shifting its long-term commercial anchor away from traditional small-molecule generics…
Read More
The Rhythmic Breath: New Scientific Evidence Links Targeted Exhalation to Bold Decision-Making
For generations, the rhythmic practice of deep, controlled breathing has been championed by practitioners of meditation, yoga, and various cultural…
Read More
Cavidi AB’s BOLD Technology Sets New Standards in Immunoassay Sensitivity and Precision for Biomedical Research and Diagnostics
Cavidi AB is making significant strides in enhancing the capabilities of immunoassays, a cornerstone technique in diagnostics and biomedical research,…
Read More
MSD’s $6.7 Billion Acquisition of Terns Pharmaceuticals Signals a Bold Strategic Pivot in Oncology to Secure Future Growth
On March 25, Merck & Co. (MSD) announced a significant strategic move, acquiring Terns Pharmaceuticals for an estimated $6.7 billion…
Read More
